Interactions of the scid or beige mutations with the viable motheaten mutation.

Détails

ID Serval
serval:BIB_E4C8A9938930
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Interactions of the scid or beige mutations with the viable motheaten mutation.
Périodique
Autoimmunity
Auteur⸱e⸱s
Dominique V., Francis L.
ISSN
0891-6934 (Print)
ISSN-L
0891-6934
Statut éditorial
Publié
Date de publication
1995
Peer-reviewed
Oui
Volume
22
Numéro
4
Pages
199-207
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Résumé
The viable motheaten (mev) mice are characterized by a moth-eaten appearance of the coat, immunodeficiency, autoimmunity, generalized inflammatory disease, paws necroses, and early death. The target of the single point mev mutation is PTP1C, a protein tyrosine phosphatase whose deficient expression in hematopoietic cells should explain all phenotypic features of mev mice, particularly their autoimmune and inflammatory pathologies. In order to evaluate their role in the development of the mev mouse disease, we constructed mevscid congenics to probe the impact of autoimmunity and mevbeige congenics to probe the impact of elastase and cathepsine G neutrophil activities. Both mevscid and mevbeige mice were nearly equivalent to mev mice with regards to moth-eaten appearance, paw necroses and early death. Thus, autoimmunity does neither initiate nor substantially enhance the mev mouse syndrome. Moreover, the beige mutation-linked deficiency of protease activity of neutrophils is unable to significantly reduce the mev mutation-dependent inflammatory pathology.

Mots-clé
Animals, Crosses, Genetic, Female, Fetal Viability/genetics, Fetal Viability/physiology, Growth/physiology, Immunoglobulins/blood, Life Expectancy/trends, Male, Mice, Mice, Inbred C57BL, Mice, Mutant Strains, Mice, SCID, Mortality/trends, Skin Diseases/genetics, Skin Diseases/mortality, Skin Diseases/pathology
Pubmed
Web of science
Création de la notice
06/10/2016 11:33
Dernière modification de la notice
20/08/2019 17:08
Données d'usage